SEOUL, Jan. 28 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Friday its 2022 net income more than doubled on strong overseas sales of its biomedicine products after its takeover of Samsung Bioepis Co. Its net income reached 798.1 billion won (US$648.1 million) in 2022, up 102.8 percent [...]
SEOUL, Jan. 16 (Korea Bizwire) — Many women might dream of someone taking full care of their period every month, ordering quality sanitary pads in a timely manner and answering embarrassing questions about menstruation and related symptoms. Happy Moonday Inc. — a Korean startup for femtech, which refers to products and services that support women’s [...]
SEOUL, Jan. 12 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Thursday it will invest 7.5 trillion won (US$6 billion) to build a new biomedicine production complex west of Seoul. Samsung Biologics CEO John Rim said in the J.P. Morgan Healthcare Conference in San Francisco that the new [...]
SEOUL, Jan. 9 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. said Monday it has signed a contract with Rani Therapeutics, a U.S. bio firm, to cooperate in developing an oral antibody medication. RT-111 is Rani’s project to develop ustekinumab, sold under the name of Stelara by Janssen Pharmaceuticals for the treatment of Crohn’s [...]
SEOUL, Jan. 5 (Korea Bizwire) — Daewoong Pharmaceutical Co., a leading South Korean drugmaker, said Thursday that it has signed a contract with Oncorus Inc., a U.S. biotech company, to cooperate in developing and commercializing messenger RNA (mRNA) drugs for cancer patients. Under the deal, the two companies will conduct joint research on the discovery [...]
SEOUL, Dec. 15 (Korea Bizwire) — The South Korean bioindustry’s output surged more than 20 percent in 2021 from a year earlier on the back of brisk exports amid the coronavirus pandemic, data showed Thursday. The industry’s production came to about 21 trillion won (US$16.2 billion) last year, up 22.1 percent from a year earlier, [...]
SEOUL, Dec. 14 (Korea Bizwire) — SK Biopharmaceuticals Co., a pharmaceutical affiliate of South Korea’s SK Group, said Wednesday it aims to transform into a global health care solutions provider based on the successful rollout of its anti-epilepsy treatment. “SK Biopharm is to become a world-leading health care solutions company that provides comprehensive services to [...]
SEOUL, Dec. 7 (Korea Bizwire) — South Korea will funnel 400 billion won (US$304.5 million) into research and development next year to foster the digital transformation in the bio technology sector as part of the country’s long-term future growth plan, the science ministry said Wednesday. The Ministry of Science and ICT released its latest digital-biotech [...]
SEOUL, Dec. 7 (Korea Bizwire) — South Korea will push for deregulation and provide various supportive measures for bio companies to promote their planned investment and nurture the sector as a new growth engine, the industry ministry said Wednesday. Samsung Biologics Co., SK Bioscience Co. and other bio firms have announced plans to invest a [...]
SEOUL, Oct. 25 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Tuesday it has signed a deal to join hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger RNA (mRNA) vaccines. Under the agreement, SK Bioscience will receive US$140 million for the project from CEPI, an Oslo-based international public-private partnership, [...]